A Sea Change In Cardiac Imaging
Interventional cardiology has been among the leading areas of medical device innovation. Yet despite the plethora of new products and procedures, a vital part of all these improvements--cardiac imaging--has largely remained unchanged over the past 40 years. Cardiac Mariners is developing a new x-ray system specifically designed to improve imaging and protect the safety of medical staff as well as patients. Even if its image quality is no better than conventional imaging methods, Cardiac Mariners' technology should have enormous appeal to interventional cardiologists because it addresses a problem these physicians have been reluctant to address: exposure to radiation.
You may also be interested in...
Woodcock’s willingness to stay on at US FDA for more than a transitional period after Robert Califf’s expected confirmation as commissioner may depend on exactly the type of authority and tasks he’d be willing to delegate to her. Plus, some other agency personnel updates.
The USP’s general chapter on nitrosamine impurities provides guidance on assessing risks and testing levels of the carcinogens in pharmaceuticals.
Novartis hopes a CAR-T with rapid manufacturing will be a winner, while novel bispecific antibodies in lymphoma and myeloma will make appearances, along with next-generation PI3K and BTK inhibitors.